Rosa Ayala

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

Joaquín Martínez‐López, Juan José Lahuerta, François Pépin et al. · Blood · 2014 · 424 citations · Full text

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

Juliane Menezes, Francesco Acquadro, Michele S. Wiseman et al. · Leukemia · 2013 · 161 citations

Hematological Malignancy, Recurrent Mutations, Medicine +10

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Alberto Álvarez‐Larrán, Arturo Pereira, Paola Guglielmelli et al. · Haematologica · 2016 · 145 citations · Full text

Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies

José María Sánchez‐Pina, Mario Rodríguez, Nerea Castro Quismondo et al. · European Journal Of Haematology · 2020 · 90 citations